Committed to developing treatments
for orphan diseases

Laurent Pharmaceuticals is an orphan drug company with a clinical development program in cystic fibrosis.  

laurent Lauren2 Laurent3

Cystic Fibrosis




Laurent Pharmaceuticals to participate at RESI on MaRS, April 10th 2018, Toronto, Canada

Laurent Pharmaceuticals to participate at the Biotech Showcase, January 8-10th 2018, San Francisco, CA, USA



Laurent Pharmaceuticals reaches agreement with US Cystic Fibrosis Foundation to increase Development Award to $US 5M

Read more  

Laurent Pharmaceuticals Receives FDA and Health Canada Clearance to Initiate APPLAUD Phase 2 Clinical Study of LAU-7b for the Treatment of Cystic Fibrosis

Read more